These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
293 related items for PubMed ID: 16015281
1. Effect of the APOC3 Sst I SNP on fasting triglyceride levels in men heterozygous for the LPL P207L deficiency. Garenc C, Couillard C, Laflamme N, Cadelis F, Gagné C, Couture P, Julien P, Bergeron J. Eur J Hum Genet; 2005 Oct; 13(10):1159-65. PubMed ID: 16015281 [Abstract] [Full Text] [Related]
2. Variation at the lipoprotein lipase and apolipoprotein AI-CIII gene loci are associated with fasting lipid and lipoprotein traits in a population sample from Iceland: interaction between genotype, gender, and smoking status. Peacock RE, Temple A, Gudnason V, Rosseneu M, Humphries SE. Genet Epidemiol; 1997 Oct; 14(3):265-82. PubMed ID: 9181356 [Abstract] [Full Text] [Related]
3. Relationship between plasma HDL subclasses distribution and lipoprotein lipase gene HindIII polymorphism in hyperlipidemia. Long S, Tian Y, Zhang R, Yang L, Xu Y, Jia L, Fu M. Clin Chim Acta; 2006 Apr; 366(1-2):316-21. PubMed ID: 16364275 [Abstract] [Full Text] [Related]
4. Polymorphisms in APOA1 and LPL genes are statistically independently associated with fasting TG in men with CAD. Souverein OW, Jukema JW, Boekholdt SM, Zwinderman AH, Tanck MW. Eur J Hum Genet; 2005 Apr; 13(4):445-51. PubMed ID: 15657615 [Abstract] [Full Text] [Related]
5. The relationship of serum lipoprotein lipase mass with fasting serum apolipoprotein B-48 and remnant-like particle triglycerides in type 2 diabetic patients. Kobayashi J, Nakajima K, Nohara A, Kawashiri M, Yagi K, Inazu A, Koizumi J, Yamagishi M, Mabuchi H. Horm Metab Res; 2007 Aug; 39(8):612-6. PubMed ID: 17712727 [Abstract] [Full Text] [Related]
6. Physical activity modulates the combined effect of a common variant of the lipoprotein lipase gene and smoking on serum triglyceride levels and high-density lipoprotein cholesterol in men. Sentí M, Elosua R, Tomás M, Sala J, Masiá R, Ordovás JM, Shen H, Marrugat J. Hum Genet; 2001 Oct; 109(4):385-92. PubMed ID: 11702219 [Abstract] [Full Text] [Related]
7. Association of lipoprotein lipase S447X, apolipoprotein E exon 4, and apoC3 -455T>C polymorphisms on the susceptibility to diabetic nephropathy. Ng MC, Baum L, So WY, Lam VK, Wang Y, Poon E, Tomlinson B, Cheng S, Lindpaintner K, Chan JC. Clin Genet; 2006 Jul; 70(1):20-8. PubMed ID: 16813599 [Abstract] [Full Text] [Related]
8. Effect of obesity on HDL and LDL particle sizes in carriers of the null P207L or defective D9N mutation in the lipoprotein lipase gene: the Québec LipD Study. Ruel IL, Gaudet D, Perron P, Bergeron J, Julien P, Lamarche B, Québec LipD Study. Int J Obes Relat Metab Disord; 2003 May; 27(5):631-7. PubMed ID: 12704407 [Abstract] [Full Text] [Related]
9. Severe hypertriglyceridemia, reduced high density lipoprotein, and neonatal death in lipoprotein lipase knockout mice. Mild hypertriglyceridemia with impaired very low density lipoprotein clearance in heterozygotes. Weinstock PH, Bisgaier CL, Aalto-Setälä K, Radner H, Ramakrishnan R, Levak-Frank S, Essenburg AD, Zechner R, Breslow JL. J Clin Invest; 1995 Dec; 96(6):2555-68. PubMed ID: 8675619 [Abstract] [Full Text] [Related]
10. [The association of S447X and Hind III polymorphism in the lipoprotein lipase gene with dyslipidemia of the metabolic syndrome in patients with essential hypertension]. Liu A, Li L, Cao W, Shan S, Lu J, Guo X, Hu Y. Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Apr; 22(2):151-7. PubMed ID: 15793775 [Abstract] [Full Text] [Related]
11. Different VLDL apo B, and HDL apo AI and apo AII metabolism in two heterozygous carriers of unrelated mutations in the lipoprotein lipase gene. Pérez-Méndez O, Duhal N, Lacroix B, Bonte JP, Fruchart JC, Luc G. Clin Chim Acta; 2006 Jun; 368(1-2):149-54. PubMed ID: 16487502 [Abstract] [Full Text] [Related]
12. Insulin sensitivity is impaired in heterozygous carriers of lipoprotein lipase deficiency. Hölzl B, Iglseder B, Sandhofer A, Malaimare L, Lang J, Paulweber B, Sandhofer F. Diabetologia; 2002 Mar; 45(3):378-84. PubMed ID: 11914743 [Abstract] [Full Text] [Related]
13. The relation of plasma triglyceride, apolipoprotein B, and high-density lipoprotein cholesterol to postheparin lipoprotein lipase activity is dependent on apolipoprotien E polymorphism. St-Amand J, Moorjanit S, Lupien PJ, Prud'homme D, Després JP. Metabolism; 1996 Feb; 45(2):261-7. PubMed ID: 8596500 [Abstract] [Full Text] [Related]
14. Association of the Sst-I polymorphism at the APOC3 gene locus with variations in lipid levels, lipoprotein subclass profiles and coronary heart disease risk: the Framingham offspring study. Russo GT, Meigs JB, Cupples LA, Demissie S, Otvos JD, Wilson PW, Lahoz C, Cucinotta D, Couture P, Mallory T, Schaefer EJ, Ordovas JM. Atherosclerosis; 2001 Sep; 158(1):173-81. PubMed ID: 11500189 [Abstract] [Full Text] [Related]
15. Influence of apolipoprotein E genotype on the reliability of the Friedewald formula in the estimation of low-density lipoprotein cholesterol concentrations. Tremblay AJ, Bergeron J, Gagné JM, Gagné C, Couture P. Metabolism; 2005 Aug; 54(8):1014-9. PubMed ID: 16092050 [Abstract] [Full Text] [Related]
16. Effect of apolipoprotein E, peroxisome proliferator-activated receptor alpha and lipoprotein lipase gene mutations on the ability of fenofibrate to improve lipid profiles and reach clinical guideline targets among hypertriglyceridemic patients. Brisson D, Ledoux K, Bossé Y, St-Pierre J, Julien P, Perron P, Hudson TJ, Vohl MC, Gaudet D. Pharmacogenetics; 2002 Jun; 12(4):313-20. PubMed ID: 12042669 [Abstract] [Full Text] [Related]